Cardinal Health Inc (NYSE:CAH) has received a consensus rating of “Hold” from the thirteen ratings firms that are covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and one has assigned a buy rating to the company. The average 12 month target price among analysts that have covered the stock in the last year is $58.90.
A number of research firms have weighed in on CAH. UBS Group began coverage on Cardinal Health in a report on Thursday, January 17th. They set a “neutral” rating and a $51.00 target price for the company. Leerink Swann lowered Cardinal Health from an “outperform” rating to a “market perform” rating and set a $55.00 target price for the company. in a report on Friday, November 16th. Zacks Investment Research raised Cardinal Health from a “sell” rating to a “hold” rating in a report on Tuesday, November 13th. ValuEngine raised Cardinal Health from a “strong sell” rating to a “sell” rating in a report on Friday, February 8th. Finally, Morgan Stanley lifted their target price on Cardinal Health from $40.00 to $50.00 and gave the company an “underweight” rating in a report on Monday, December 3rd.
Shares of CAH opened at $55.91 on Friday. Cardinal Health has a fifty-two week low of $42.17 and a fifty-two week high of $73.23. The stock has a market capitalization of $16.92 billion, a P/E ratio of 11.18, a PEG ratio of 1.80 and a beta of 1.16. The company has a quick ratio of 0.51, a current ratio of 1.05 and a debt-to-equity ratio of 1.26.
Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, February 7th. The company reported $1.29 earnings per share for the quarter, topping the consensus estimate of $1.09 by $0.20. Cardinal Health had a positive return on equity of 24.01% and a negative net margin of 0.03%. The company had revenue of $37.70 billion during the quarter, compared to analyst estimates of $36.09 billion. During the same quarter last year, the firm posted $1.31 EPS. The firm’s revenue for the quarter was up 7.1% on a year-over-year basis. Sell-side analysts expect that Cardinal Health will post 5.08 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Monday, April 15th. Shareholders of record on Monday, April 1st will be issued a dividend of $0.4763 per share. This represents a $1.91 dividend on an annualized basis and a yield of 3.41%. The ex-dividend date of this dividend is Friday, March 29th. Cardinal Health’s payout ratio is presently 38.20%.
Cardinal Health declared that its board has authorized a share buyback plan on Thursday, November 8th that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the company to buy up to 6.4% of its shares through open market purchases. Shares buyback plans are often a sign that the company’s leadership believes its shares are undervalued.
A number of hedge funds have recently bought and sold shares of the business. Cetera Advisor Networks LLC boosted its position in shares of Cardinal Health by 2.6% during the 4th quarter. Cetera Advisor Networks LLC now owns 7,566 shares of the company’s stock valued at $336,000 after acquiring an additional 195 shares during the last quarter. Advisory Services Network LLC boosted its position in shares of Cardinal Health by 15.1% during the 4th quarter. Advisory Services Network LLC now owns 1,497 shares of the company’s stock valued at $67,000 after acquiring an additional 196 shares during the last quarter. Eaton Vance Management boosted its position in shares of Cardinal Health by 0.3% during the 4th quarter. Eaton Vance Management now owns 79,011 shares of the company’s stock valued at $3,524,000 after acquiring an additional 237 shares during the last quarter. Toth Financial Advisory Corp boosted its position in shares of Cardinal Health by 5.2% during the 4th quarter. Toth Financial Advisory Corp now owns 6,857 shares of the company’s stock valued at $306,000 after acquiring an additional 339 shares during the last quarter. Finally, Gemmer Asset Management LLC boosted its position in shares of Cardinal Health by 172.4% during the 4th quarter. Gemmer Asset Management LLC now owns 553 shares of the company’s stock valued at $25,000 after acquiring an additional 350 shares during the last quarter. 89.10% of the stock is owned by institutional investors and hedge funds.
Cardinal Health Company Profile
Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.
Further Reading: Bond
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.